生命科学资讯
生物技术与制药领域的最新动态
FDA tackles BP wearables in new draft guidance
AI identifies pregnancies at risk of spontaneous pre-term birth
Legislation seeks to guard NIH from politicization
Researchers develop Revoice for stroke patients
研究人员开发出3,3-二甲基-2-氧代吲哚啉STING抑制剂
Researchers develop 3,3-dimethyl-2-oxoindiline STING inhibitors
基因疗法在心脏传导阻滞模型中诱导生物起搏器生成
Gene therapy induces biological pacemakers in heart block models
新型TTK抑制剂用于三阴性乳腺癌治疗
Novel TTK inhibitor for TNBC therapy
靶向DUX4可改善FSHD模型中的肌肉功能。
Targeting DUX4 with improves muscle function in FSHD models
Janux的肿瘤激活平台吸引BMS达成潜在8.5亿美元交易
Janux’s tumor-activated platform draws BMS in potential $850M deal
2026年1月22日人事任命与晋升动态
Appointments and advancements for Jan. 22, 2026
2026年1月22日融资动态
Financings for Jan. 22, 2026
2026年1月22日其他值得关注的新闻
Other news to note for Jan. 22, 2026
2026年1月22日监管动态
Regulatory actions for Jan. 22, 2026
Corcept的relacorilant有望进军21亿美元卵巢癌市场。
Corcept’s relacorilant could reach $2.1B ovarian cancer market
Rezubio制药公司公开新型药物偶联物用于治疗纤维化
Rezubio Pharmaceuticals discloses new drug conjugates to treat fibrosis
鲁南新时代生物技术报告新型喜树碱衍生物及其抗体药物偶联物
Lunan New Time Biotechnical reports new camptothecin derivatives and their ADCs
上海青润医药科技成功合成新型GTP酶KRAS突变抑制剂
Shanghai Qingrun Pharmaceutical Technology synthesizes new GTPase KRAS mutant inhibitors
Beyang Therapeutics发现VEGFR抑制剂盐类
Beyang Therapeutics discovers salts of VEGFR inhibitors
阳光湖药业披露新型PKMYT1抑制剂
Sunshine Lake Pharma divulges new PKMYT1 inhibitors